Clinical Trial Update: A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial update reports the termination of a Phase 1/Phase 2 study evaluating Holmium-166-DOTMP for skeletal-targeted radiotherapy in patients with mu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Holmium-166 DOTMP (holmium-166 DOTMP)

Snippet

Sponsor: Poniard Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: TERMINATED